Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.27B |
| 2 |
Blackrock
BLK
|
+$1.21B |
| 3 |
PG&E
PCG
|
+$1.17B |
| 4 |
Alibaba
BABA
|
+$1.12B |
| 5 |
T-Mobile US
TMUS
|
+$826M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$1.34B |
| 2 |
Boston Scientific
BSX
|
+$1.26B |
| 3 |
American Express
AXP
|
+$1.23B |
| 4 |
GE Aerospace
GE
|
+$1.1B |
| 5 |
Visa
V
|
+$993M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.88% |
| 2 | Healthcare | 16.37% |
| 3 | Consumer Discretionary | 13.18% |
| 4 | Financials | 11.24% |
| 5 | Communication Services | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Cardinal Health
CAH
$55.4B
| $306M | 0.03% |
5,859,876
-888,593
| -13% | -$45.8M |
|
452
Biogen
BIIB
$30.7B
| $306M | 0.03% |
1,142,394
-1,045,442
| -48% | -$314M |
|
453
Synaptics
SYNA
$4.15B
| $305M | 0.03% |
5,073,249
+1,074,603
| +27% | +$67.4M |
|
454
United Therapeutics
UTHR
$23.1B
| $305M | 0.03% |
2,517,046
+8,187
| +0.3% | +$921K |
|
455
RenaissanceRe
RNR
$13.4B
| $304M | 0.03% |
1,778,438
+756,289
| +74% | +$124M |
|
456
Alexandria Real Estate Equities
ARE
$8.56B
| $303M | 0.03% |
1,870,336
-912,219
| -33% | -$139M |
|
457
Unum
UNM
$14.3B
| $303M | 0.03% |
18,283,812
+36,745
| +0.2% | +$580K |
|
|
LHCG
458
DELISTED
LHC Group LLC
LHCG
| $302M | 0.03% |
1,731,906
+24,316
| +1% | +$3.57M |
|
459
Agios Pharmaceuticals
AGIO
$1.93B
| $300M | 0.03% |
5,616,327
-3,379,252
| -38% | -$156M |
|
460
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
| $300M | 0.03% |
2,095,456
-83,050
| -4% | -$11.2M |
|
461
FirstEnergy
FE
$27.5B
| $299M | 0.03% |
7,708,855
+266,810
| +4% | +$11M |
|
462
Skyworks Solutions
SWKS
$10.6B
| $298M | 0.03% |
2,327,563
-803,002
| -26% | -$89M |
|
463
IQVIA
IQV
$39.3B
| $297M | 0.03% |
2,090,227
-378,828
| -15% | -$51.3M |
|
464
Spectrum Brands
SPB
$2.07B
| $296M | 0.03% |
6,458,407
-425,722
| -6% | -$18.1M |
|
|
PRNB
465
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $296M | 0.03% |
4,956,097
+4,832
| +0.1% | +$298K |
|
|
PS
466
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $295M | 0.03% |
16,320,897
+2,521,349
| +18% | +$42.7M |
|
467
Trimble
TRMB
$13.9B
| $294M | 0.03% |
6,802,721
+901,337
| +15% | +$33.8M |
|
468
Raymond James Financial
RJF
$34B
| $293M | 0.03% |
6,394,514
-499,347
| -7% | -$22.5M |
|
469
Extra Space Storage
EXR
$31.6B
| $293M | 0.03% |
3,176,258
+102,142
| +3% | +$9.49M |
|
|
BPMC
470
DELISTED
Blueprint Medicines
BPMC
| $293M | 0.03% |
3,760,541
-1,347,178
| -26% | -$91.1M |
|
471
Oshkosh
OSK
$9.59B
| $293M | 0.03% |
4,087,008
+534,203
| +15% | +$36.5M |
|
472
Snap
SNAP
$9.01B
| $285M | 0.03% |
12,131,595
+8,557,956
| +239% | +$152M |
|
473
LXP Industrial Trust
LXP
$3.57B
| $283M | 0.03% |
5,358,321
+1,017,340
| +23% | +$51.3M |
|
474
Illinois Tool Works
ITW
$85.3B
| $280M | 0.03% |
1,602,863
+428,601
| +36% | +$70M |
|
475
Douglas Emmett
DEI
$1.96B
| $279M | 0.03% |
9,090,612
+3,555,837
| +64% | +$107M |
|
Similar funds
Fidelity Investments's Q2 2020 Portfolio in Review
As of Q2 2020, Fidelity Investments held 4,490 positions worth $909B, up 26% from $722B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Fidelity Investments's Q2 2020 filing shows 334 new, 1,365 increased, 1,743 reduced and 502 closed positions. Its largest new stake was Royalty Pharma: 16,356,491 shares worth $743M. The largest sale was iShares US Treasury Bond ETF, an estimated $1.34B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fidelity Investments's largest Q2 2020 buy was Royalty Pharma: 16,356,491 shares worth $743M.
- Fidelity Investments added most to Regeneron Pharmaceuticals in Q2 2020, an estimated $2.27B increase.
- Fidelity Investments's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.34B.
- Fidelity Investments fully exited Sprint Corporation in Q2 2020, selling an estimated $225M.
- Fidelity Investments's ten largest holdings make up 28% of its $909B portfolio in Q2 2020.
- Fidelity Investments opened 334 new positions and closed 502 in Q2 2020.
- Fidelity Investments's portfolio value rose 26% quarter-over-quarter to $909B.
Based on Fidelity Investments's 13F filing for Q2 2020, filed 13 Aug 2020.